Collagen Dysregulation in the Dermis of the Sagg/+ Mouse: A Loose Skin Model  by Christner, Paul J. et al.
Collagen Dysregulation in the Dermis of the Sagg/þ
Mouse: A Loose Skin Model
Paul J. Christner1, Julieta Gentiletti1, Josephine Peters2, Simon T. Ball2, Mitsuo Yamauchi3,
Phimon Atsawasuwan3, David P. Beason4, Louis J. Soslowsky4 and David E. Birk5
The Sagg/þ mouse is an ethylnitrosourea-derived mutant with a dermal phenotype similar to some of the
subtypes of Ehlers–Danlos syndrome (EDS) and cutis laxa. The dermis of the Sagg/þ mouse has less dense and
more disorganized collagen fibers compared to controls. The size of extracted Type I dermal collagen was the
same as that observed in normal skin; however, more collagen could be extracted from Sagg/þ skin, which also
showed decreased collagen content and decreased steady-state levels of a1(I), a2(I), a1(V), and a2(V)
procollagen mRNAs. The biomechanical properties of Sagg/þ skin were significantly decreased relative to
normal skin. However, there were no significant differences in the quantities of the major collagen cross-links,
that is, dehydrohydroxylysinonorleucine and dehydrohistidinohydroxymerodesmosine between Sagg/þ and
normal skin. Electron microscopic evaluation of Sagg/þ skin indicated that the mutation interferes with the
proper formation of collagen fibrils and the data are consistent with a mutation in Type V collagen leading to
haploinsufficiency with the formation of two sub-populations of collagen fibrils, one normal and one with
irregular shape and a larger diameter. Further study of this novel mutation will allow the identification of new
mechanisms involved in the regulation of normal and pathologic collagen gene expression.
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INTRODUCTION
Animal models have proven to be of great value in enhancing
the understanding of biologically complex systems. They
have facilitated the elucidation of the pathogenesis of
numerous diseases, and have provided the means to test
potentially useful therapeutic interventions. The Sagg muta-
tion appeared in the offspring of a mouse that had been
administered ethylnitrosourea and was named Sagg because
of the saggy or loose skin observed in affected animals (Nolan
et al., 2000). The mutation is inherited in an autosomal
dominant manner and is located on proximal chromosome 1
(Nolan et al., 2000). No other studies have been reported on
Sagg. The occurrence of a novel mutation that results in loose
skin is of relevance to several connective tissue diseases such
as Ehlers–Danlos syndrome (EDS) and cutis laxa.
EDS is a collection of diseases that affect approximately
one in 5,000 live births, including men and women of all
racial and ethnic groups. EDS comprises a heterogeneous
group of hereditary connective tissue disorders, characterized
by hyperelasticity of skin and hypermobility of joints to
differing extents. The skin is easily injured and wound healing
is delayed (Steinmann et al., 2002). The molecular causes of
this disorder are often, although not strictly, related to
collagens and to the enzymes that process these proteins.
The majority of EDS patients belong to EDS types I–III. Using
the classification of Beighton et al. (1998), the classical forms
of EDS, types I and II, can be caused by mutations in collagen
V, whereas the cause of EDS type III (hypermobility type) is
not known. The vascular type of EDS is caused by mutations
in collagen type III (Pope et al., 1977; Superti-Furga et al.,
1989); the kyphoscoliosis type of EDS is caused by mutations
in lysyl hydroxylase-1 (Yeowell and Walker, 2000); the
arthrochalasia type of EDS is caused by mutations in type I
procollagen (Wirtz et al., 1987); and the dermatosparaxis
type of EDS is caused by mutations in the procollagen-N-
peptidase (De Paepe and Malfait, 2004). Tenascin-X has also
been demonstrated to be involved in some forms of EDS
(Zweers et al., 2004; Lindor and Bristow, 2005). Moreover,
gene disruption of several other matrix molecules, thrombo-
spondin, SPARC (secretory protein acidic and rich in
cysteine), small leucine-rich proteoglycans, and others in
mice, leads to phenotypes that mimic EDS, and these
molecules have thus emerged as new players (Jepsen et al.,
2002; Fichard et al., 2003).
Cutis laxa is a set of connective tissue diseases of the skin
characterized by sagging skin, premature wrinkling, and
reduced skin elasticity (Uitto and Shamban, 1987; Boulac
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et al., 1999; Zlotogora, 1999). It can occur both as an
acquired (Boulac et al., 1999; Ozkan et al., 1999; Braakenburg
and Nicolai, 2000) and as a genetic disease (Damkier et al.,
1991; Imaizumi et al., 1994; Rybojad et al., 1999), and can
be accompanied by marfanoid symptoms (Larregue et al.,
1990), pulmonary artery stenosis (Hayden et al., 1968) skin
webbing (O’Brien et al., 1970), cardiac valve involvement
(Baldwin et al., 2001), osteoma cutis (Choi et al., 2000), loss
of psychomotor abilities (Shintaku et al., 2000), and joint
hypermobility (Robertson and Bankier, 1999). A specific
X-linked form of cutis laxa also was classified as one of the
rare EDS (Mentzel et al., 1999). Molecular abnormalities
identified to date include chromosome 16 abnormalities
(Garson et al., 1970) diminished elastin in the skin with an accom-
panying increase in the fibrillar components of the elastic
fibers (Kitano et al., 1989), increased elastase activity (Boulac
et al., 1999), and increased collagenase activity, leading to a
decrease in collagen (Hatamochi et al., 1991).
Although there are several genes that have been identified
as causative for these diseases, only the wrinkly skin
syndrome form of cutis laxa (Hurvitz et al, 1990; Zlotogora,
1999) and Ehlers–Danlos forms I, II, and IV (De Paepe and
Malfait, 2004) have been linked to mutations in genes for
which the mouse orthologs reside in the identified Sagg
interval on the proximal arm of mouse chromosome 1 (Nolan
et al., 2000).
RESULTS
Gross appearance
The Sagg/þ mice had normal growth, development, and
survival. The Sagg/þ mice were first recognizable at 2–3
months of age by the looseness of their skin in the
interscapular region. When each mouse was picked up with
forceps from the interscapular region of the back, the distance
the Sagg/þ mice hang below the forceps is greater than that
for normal mice (Figure 1). For the experiments reported here,
only 3-month-old mice were investigated and both pheno-
typic and simple sequence length polymorphism (SSLP)
analyses were performed on each mouse.
Histologic examination
Histologic examination of skin samples from 3-month-old
normal mice (Figure 2a; 100) compared to skin samples
from Sagg/þ mice (Figure 2b; 100) showed a thinning of
the deep dermis near the panniculus carnosus. At 400
magnification, the Sagg/þ dermis shows significant disorga-
nization of the collagen fibers (Figure 2d) that are less tightly
packed and have clearly evident spaces. The difference in the
staining intensity with the Mason’s trichrome stain is striking
at this higher magnification (Figure 2c vs d). Sections of Sagg/þ
dermis stained less intensely than the normal (not as dark
blue) in over 20 different sections (10 Sagg/þ and 10
normal), suggesting that the fibers and fibrils are less densely
packed.
Collagen content of skin
Hydroxyproline content of skin biopsy punches obtained
from eight Sagg/þ and five age-matched normal mice was
determined. On average, the hydroxyproline content of the
dermis of Sagg/þ mice was approximately one-third that
found in the dermis of normal mice, 2379 vs 72710 mg
hydroxyproline per mg dry weight, Po0.005 (Table 1).
The quantitative or qualitative differences in the popula-
tions of the collagenous proteins of normal and Sagg/þ skin
were measured by sequential extraction with neutral-salt
buffer and 0.5 M acetic acid. The neutral-salt extract from
Sagg/þ and control mice showed identical collagen species
when electrophoresed by SDS-PAGE, indicating there were
no qualitative differences (Figure 3). Similar results were
observed for the acid extract (results not shown). Quantitative
differences between extractable dermal collagen from Sagg/þ
and control mice were determined using a constant
ratio of extraction buffer to wet weight of the skin and
Normal Sagg/+a b
Figure 1. Photograph of a (a) normal and (b) Sagg/þ mouse showing the
difference in the ability of the skin to be stretched. Notice that the normal
mouse has been lifted off its front feet, whereas the Sagg/þ mouse has not,
and even with the increased pull on the normal mouse, more skin can be
drawn away from the Sagg/þ mouse.
Normal Sagg/+
a b
c d
Figure 2. Light photomicrographs of skin sections from 3-month-old (a), (c)
normal and (b), (d) Sagg/þ mice stained with Mason’s trichrome. Note the
marked decrease in blue-staining collagen fibers in the skin from Sagg/þ
mice compared with normal mice. Top panels are at original magnification
100 and bottom panels are at original magnification 400.
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electrophoresing equal aliquots of extracts. The results
demonstrate that the Sagg/þ dermis had more extractable
collagen than the controls (Figure 4).
A densitometric comparison of the a1 and a2 bands
indicated that approximately 8- and 2-fold more collagen
was extractable from Sagg/þ skin with neutral-salt buffer and
acetic acid, respectively, compared to controls. The in-
creased extractability of the collagen from the skin of Sagg/þ
mice suggests possible differences in the collagen cross-
linking.
Collagen cross-linking
A cross-link analysis was performed on the skins of each type
of mouse. The major collagen cross-links of both Sagg/þ and
control mice were reducible cross-links, dehydrohydroxy-
lysinonorleucine and dehydrohistidinohydroxymerodesmo-
sine. The non-reducible, mature cross-links such as
pyridinoline or histidino-hydroxylysinonorleucine (Yamauchi
et al., 1987) were under detectable levels. The results
demonstrate that there were no significant differences in the
collagen cross-linking between Sagg/þ and control (þ /þ )
mice (Table 2).
Steady-state levels of a1(I) procollagen mRNA in Sagg/þ skin
The steady-state levels of a1(I) procollagen mRNA in skin
samples of Sagg/þ and normal littermate controls were
compared by Northern hybridizations or real-time PCR. The
Northern analyses employed a species-specific cDNA. The
levels of a1(I) procollagen transcripts were substantially lower
in Sagg/þ skin than in normal mouse skin (Figure 5). The
decrease in a1(I) procollagen mRNA in Sagg/þ mouse skin
was consistent in repeated analyses of RNA obtained from the
same mouse; however, there was some variability in the level
of decrease between individual mice (Figure 5).
The results of a semiquantitative analysis of the Northern
blots by densitometry followed by correction for loading and
transfer of RNA by hybridization to a rat glyceraldehyde-3-
phosphate dehydrogenase cDNA indicated that the steady-
state level of a1(I) procollagen mRNA transcripts in Sagg/þ
dermal fibroblasts was 23714% of that found in normal
dermal fibroblasts.
Additional experiments were performed with real-time
PCR to determine the message levels for Col1a2, Col3a1,
Col5a1, and Col5a2. The results were normalized to b-actin
and are expressed as a percentage of the message levels
Table 1. Hydroxyproline content of skin samples from
Sagg/+ mice and normal littermates
lg hydroxyproline/mg dry weight
Mouse Normal Sagg/+
1 51.5 18.4
61.4 18.9
2 69.7 18.9
69.9 18.9
3 73.2 18.9
75.4 18.9
4 77.0 19.0
77.2 19.0
5 82.9 19.0
83.0 19.0
6 19.1
19.2
7 20.7
35.7
8 41.7
46.9
AVG 72.1 23.3
SD 9.7 9.2
Duplicate 4-mm-diameter biopsy samples were obtained from the
interscapular region of each animal. Following lyophilization to deter-
mine their dry weight, samples were hydrolyzed and their hydroxyproline
content determined by the method of Woessner (1961). The average
(AVG) difference between the results of Sagg/+ skin and normal is significant
to Po0.005 by the Student’s t-test.


1 2 3 4 5 6
Figure 3. SDS-PAGE of Coomassie blue stained salt extracts from the skin of
(lanes 1–3) normal and (lanes 4–6) Sagg/þ mice. Fifty micrograms of protein
were electrophoresed in each lane. An arrow indicates the positions of the
collagen a- and b-chains.


1 2 3 4 5 6
1 2 3 4 5 6
a b
Figure 4. SDS-PAGE of Coomassie blue-stained salt extracts from the skin of
(lanes 1–3) normal and (lanes 4–6) Sagg/þ mice. Ten microliters of extract
were electrophoresed in each lane. (a) Salt extract and (b) acetic acid extract.
Extractions were performed at a fixed ratio of 1 ml of extraction medium per
100 mg (wet weight) of skin. An arrow indicates the positions of the collagen
a- and b-chains.
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detected in the normal skin of age- and sex-matched mice
(Figure 6). The results show that the message levels for each
of the above four genes in the skin of Sagg/þ mice were 67,
94, 78, and 68%, respectively, of the levels observed in
normal control mouse skin. The differences in the values for
Col1a2 and Col5a2 between normal and Sagg/þ skin were
significant at Po0.05 and are highlighted in Figure 6 as
striped bars.
Electron microscopic examination of Sagg/þ skin
Electron microscopic studies were performed on the dermis
of Sagg/þ mice and normal age-matched controls. The
dermis of the control animals was composed of a relatively
homogeneous population of cylindrical collagen fibrils
(Figure 7a). In contrast, the dermis of the Sagg/þ mice
contained a population of cylindrical fibrils that were
comparable to those seen in the dermis of control mice and
a second population of structurally abnormal fibrils (Figure
7b). These fibrils were considerably larger than the fibrils with
circular cross-sectional profiles and had irregular contours
(Figure 7b, arrows).
Morphometric differences between Sagg/þ skin and normal
skin
In an attempt to quantify this difference observed between
Sagg/þ and normal skin at the electron microscopic level,
the number of fibrils present in twenty 1,200 by 1,200 nm
squares was counted from five normal and five Sagg/þ mice.
The average of the total number of fibrils in the normal skin
was 72, whereas the number observed in the Sagg/þ skin
was 35. The Sagg/þ mouse skin had approximately one-half
the number of fibrils per unit area compared to the normal
skin. In addition, the normal fibrils never exceeded 150 nm in
diameter, whereas there were at least 10 abnormal Sagg/þ
Table 2. Quantitation of cross-links in Sagg/+ and
normal mouse skin
Mouse deH-HLNL Mouse deH-HLNL
+/+ 0.060 Sagg/+ 0.045
+/+ 0.037 Sagg/+ 0.043
+/+ 0.059 Sagg/+ 0.052
+/+ 0.043 Sagg/+ 0.047
+/+ 0.042
AVG 0.048 AVG 0.047
SD 0.011 SD 0.004
Mouse deH-HHMD Mouse deH-HHMD
+/+ 0.403 Sagg/+ 0.276
+/+ 0.334 Sagg/+ 0.252
+/+ 0.122 Sagg/+ 0.205
+/+ 0.187 Sagg/+ 0.252
+/+ 0.151
AVG 0.240 0.246
SD 0.122 0.030
Skin samples weighing approximately 2 mg were analyzed from five
control (+/+) and four Sagg/+ mice to determine the amount of the
collagen cross-links: dehydrohydroxylysinonorleucine (deH-HLNL) and
dehydrohistidinohydroxymerodesmosine (deH-HHMD). The quantities of
the cross-links are expressed as mol/mol of collagen using a value of 300
residues of hydroxyproline per collagen molecule. The average (AVG)
values and standard deviations (SD) for the amount of each type of cross-
link for each of the two groups of mice are shown. There was no
statistically significant difference between +/+ and Sagg/+ skin for either
type of cross-link.
1(I)
GAPDH→
→
1 2 3 4
Figure 5. Northern hybridization analysis of total RNA extracted from the
skin of (lanes 1 and 2) normal and (lanes 3 and 4) Sagg/þ mice. The blot was
hybridized with a rat a1(I) procollagen cDNA and with a cDNA for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The positions of the
a1(I) procollagen and GAPDH transcripts are shown.
Comparison of collagen mRNA levels in normal
and Sagg /+ mouse skin
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Figure 6. Results of a real-time PCR, which amplified Col1a2, Col3a1,
Col5a1, and Col5a2. The relative expression of mRNA extracted from the skin
of normal and Sagg/þ age- and sex-matched mice was normalized to b-actin
and then expressed as a percent of the value obtained for normal skin. Error
bars indicate71 standard deviation. The differences between normal and
Sagg/þ message levels for Col1a2 and Col5a2 were significant at Po0.05
and are highlighted as striped bars.
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fibrils (Figure 7b) with a diameter exceeding 300 nm and one
fibril that exceeded 450 nm in diameter.
Differences in mechanical properties of Sagg/þ and normal
skin
Tensile tests were carried out to determine if the differences
observed in the amount of collagen (Figures 1 and 4) as well
as the differences observed in the fibril architecture (Figure 7)
had an effect on the material and structural properties of
Sagg/þ skin. Normal mouse skin was found to be
consistently and significantly higher than Sagg/þ skin for
maximum load (P¼0.0001), maximum stress (Po0.0001),
stiffness (Po0.001), and modulus (Po0.001) (see Figure 8).
DISCUSSION
The work reported here is the first step in characterizing the
Sagg/þ mouse phenotype with the eventual goal of
identifying the responsible mutation and understanding the
mechanisms whereby it leads to decreased collagen accu-
mulation as well as aberrant collagen fibril size and shape. A
wider consequence of these studies is that they will lead to a
better understanding of the complex regulatory mechanisms
controlling the expression of the collagen gene(s) under both
normal and altered pathologic conditions.
Histologic examination of skin samples from Sagg/þ mice
showed marked thinning of the dermis and depleted
deposition of collagen compared to controls. Patients with
cutis laxa have been reported to have similar changes in their
collagen fibers; however, when present, they are believed to
be a secondary result caused by the abnormalities in the
elastic fiber (Uitto and Pulkkinen, 2002). There are also
reports of increased collagen mRNA (Jung et al., 1996), and
increased collagen synthesis (Taieb et al., 1987), decreased
size of the collagen a-chains (Tsukahara et al., 1988) and
increased collagenase (Hatamochi et al., 1991). These
different findings are most likely due to the fact that cutis
laxa is comprised of several connective tissue diseases
(Hayden et al., 1968; O’Brien et al., 1970; Larregue et al.,
1990; Robertson and Bankier, 1999; Mentzel et al., 1999;
Choi et al., 2000; Shintaku et al., 2000; Baldwin et al., 2001).
Wrinkly skin syndrome, a type of cutis laxa (Zlotogora, 1999)
has been localized to chromosome 2q32 (Kreutz and
Wittwer, 1993), which contains the genes COL3A1 and
COL5A2 and is syntenic to the region of chromosome 1
where these collagen genes and Sagg are located in the
mouse (Christner et al., 1996; Nolan et al., 2000). COL3A1
and COL5A2 have been suggested as candidate genes for
wrinkly skin syndrome (Kreutz and Wittwer, 1993) and a
mutation in either of the above collagen genes may be the
cause of wrinkly skin syndrome. The work of Nolan et al.
(2000) that mapped the Sagg mutation to proximal chromo-
some 1 makes Col3a1 and Col5a2 both reasonable candidate
genes for Sagg. However, Col3a1 seems less likely to be the
candidate gene, because mutations in COL3A1 have been
reported to cause vascular involvement (Giunta and Stein-
mann, 2000), which is absent in Sagg/þ mice. The Sagg/þ
mouse did not show any visceral changes by histological
examination (data not shown). In addition, we also found
decreased collagen content and lowered steady-state levels
of a1(I), a2(I), a1(V), and a2(V), procollagen mRNA in the
Sagg/þ mouse skin compared to that found in the skin
from normal mice, but no significant decrease in a1(III)
message levels.
The biomechanical properties of the Sagg/þ skin were
markedly different from those of the normal skin, indicating
that the difference in collagen content and architecture does
indeed affect the strength and elasticity of the Sagg/þ skin.
Electron microscopic analyses demonstrated the presence of
numerous irregular oversized collagen fibrils, suggesting the
possibility that the collagen of these fibrils is abnormal or that
another extracellular matrix component protein associated
with the collagen fibrils might be abnormal. This conclusion
is supported by the fact that the collagen in the Sagg/þ
dermis is more easily extracted with both salt and acid.
Although the above findings seen in Sagg/þ mice, that is,
impaired mechanical properties and increased extractability
of skin collagen, would indicate a defective cross-linking
profile in these mice, there are no significant differences in
Normal Sagg/+
a b
Figure 7. Electron micrograph of the dermis from a (a) normal and (b) a
Sagg/þ mouse in cross-section. The collagen fibrils are clearly evident.
Several of the strikingly irregular fibrils from the Sagg/þ dermis (b) are
marked with an arrow.
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Figure 8. Mechanical properties of Sagg/þ and normal mouse skin.
Significant differences were found between normal and Sagg/þ mice for
maximum load (P¼0.0001), maximum stress (Po0.0001), stiffness
(Po0.001), and modulus (Po0.001).
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collagen cross-links between Sagg and control mice (Table 2).
These data indicate that neither the gene expression nor the
activity of lysyl oxidase is significantly altered in Sagg/þ
mice. A likely explanation for these data is that the saggy skin
phenotype and the hyperextractability of the collagen from
the skin are due to the aberrant type I collagen fibrillogenesis,
which is clearly seen in Figure 7.
Type V collagen is known to mediate the initiation and
formation of collagen fibrils and is a key determinant in the
assembly of tissue-specific matrices (Birk et al., 1988; Birk
et al., 1990; Marchant et al., 1996; Wenstrup et al., 2004a, b;
Birk, 2001). A mutation in this molecule would explain the
phenotype reported here for Sagg/þ mice. Wenstrup et al.
(2004a) reported that Col5a1þ / mice had a reduction in
both fibril content and dermal collagen content. These
findings are similar to what we report for the Sagg/þ mice.
In addition, the electron micrographs shown by Wenstrup
et al. (2004a) are almost identical to those we show for Sagg/þ
mice. Both the Col5a1 heterozygote and the Sagg/þ
mouse have numerous irregular fibrils, the irregular shape is
similar in both mutants, and they are similarly increased in
size. Sagg cannot be a mutation in Col5a1 as that gene lies on
another chromosome. However, Col5a2 is located within the
Sagg interval on chromosome 1 (Nolan et al., 2000). We
favor the hypothesis that Sagg is a mutation in the Col5a2
gene, because the collagen type I fibril abnormalities
observed in Sagg/þ mice are similar to that reported by
Wenstrup et al. (2004a, b) and because the Sagg/þ mouse
shares some of the features of a complex mouse model repo-
rted by Andrikopoulos et al. (1995) and Chanut-Delalande
et al. (2004) with a mutation in Col5a2. Studies are currently
underway to determine whether Sagg is the result of a
mutation in Col5a2.
MATERIALS AND METHODS
Animals
Breeding pairs of 3-month-old Sagg/þ mice from the MRC
Mammalian Genetics Unit (Harwell, UK) were housed in a fully
accredited AALAC (American Association for Accreditation of
Laboratory Animal Care) facility and the Thomas Jefferson Uni-
versity’s institutional animal care and use committee approved all
experiments. The mutation arose on the BALB/cJ background and
was received on hybrid (C3H/HeJBALB/cJ) F1 mice. Animals used
for the experiment had been crossed at least five generations onto
C3H/HeJ (Jackson Laboratories, Bar Harbor, ME). Sagg/þ and
matched normal littermates 3714 months of age were used. All mice
were classified as either Sagg or normal by SSLP analyses of
D1Mit18 and by the phenotypic procedure described in the Results
section. All mice described in these experiments were male, because
the level of penetrance for the Sagg phenotype was more consistent
in males than in females, although equal numbers of males and
females were affected.
Histology
For histopathologic studies, full-thickness samples of skin, including
subcutaneous tissue and deep fascia, were obtained from 10 Sagg/þ
mice and 10 age-matched þ /þ mice at 3 months of age. Samples
were processed and stained with hematoxylin–eosin and Masson’s
trichrome (Fisher, Philadelphia, PA) as described previously (Jime´nez
et al., 1984).
Transmission electron microscopy
Subscapular skin from male animals was used in these experiments.
Transmission electron microscopy was carried out as described
previously (Birk and Trelstad, 1984; Birk et al., 1997). Sections were
examined and photographed at 75 kV using a Hitachi 7000
transmission electron microscope (Schaumburg, IL).
Quantitative collagen assays
To measure the collagen content of skin, equal diameter skin
samples were obtained from the interscapular region of each mouse
with a 4 mm disposable biopsy punch (Chester A Baker Laboratories,
Miami, FL) following depilation with Nair (Shop-Rite, Philadelphia,
PA). Hydroxyproline determination was performed according to the
procedure of Woessner (1961). Total protein content of the
hydrolysate was determined by either a Ninhydrin assay (Jime´nez
and Bashey, 1978) or a bicinchoninic acid assay (Smith et al., 1985).
Collagen extraction and gel electrophoresis
For extraction of skin collagen, approximately equal samples of
interscapular skin from normal and Sagg/þ mice were obtained
after depilation with Nair. The samples were extracted with 1.0 M
NaCl at 41C with shaking for 5 days. The ratio of skin (wet weight) to
extraction buffer was 100 mg/ml of extract. After 5 days, the skin
samples were removed from the salt extract and further extracted
with the same volume of 0.5 M acetic acid at 41C for an additional 5
days. The extracted collagen from the skin of normal and Sagg/þ
mice was analyzed by polyacrylamide slab gel electrophoresis
according to the method of Laemmli (1970). Sample buffer
contained 1% SDS, 1% b-mercaptoethanol, and electrophoresis
was performed using 10% gels, which were stained with Coomassie
blue (Fisher, Philadelphia, PA).
RNA extraction
Total RNA from skin was obtained using the acid–guanidium-
thiocyanate–phenol–chloroform method of Chomcyznski and Sacchi
(1987). Briefly, tissues were homogenized with a Tekmar polytron
(Tekmar-Dohrmann, Mason, OH) and particulate material removed
by centrifugation. RNA purity was assessed by the 260/280 nm
absorbance ratio and the amount of RNA was calculated using the
conversion factor of 40mg RNA per optical density unit at 260 nm.
Northern hybridizations
Northern hybridizations of total RNA were performed according to
the method of Sambrook et al. (1989). Samples of total RNA
obtained from normal and Sagg/þ mouse skins were hybridized
with 32P-labeled murine a1(I) procollagen cDNA (French et al.,
1985) or glyceraldehyde-3-phosphate dehydrogenase cDNA (Fort
et al., 1985). After hybridizations, the filters were washed, air-dried,
exposed to X-ray film with an intensifying screen, and scanned on a
Joyce-Loebl densitometer (Gateshead, UK).
Real-time PCR
RNA was prepared as above and then used as template to produce
cDNA with SuperScript III First Strand kit (Invitrogen, Carlsbad, CA).
Probes were designed using Primer Express 2.0v software (Applied
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Bioscience, Foster City, CA) for Col1a2, Col3a1, Col5a1, and
Col5a2. Specificity of each probe was checked using the NCBI
BLAST website. The PCR was carried out in a MyiQ Real-time PCR
machine (BioRad Laboratories, Hercules, CA) with cyber green
(Cyber Green PCR Master Mix; Applied Biosystems, Foster City, CA)
as the reporter. MyiQ Optical System software 1.0v was used
(BioRad Laboratories, Hercules, CA) to analyze the data. All results
were normalized to the amount of b-actin in the sample. Values
of P were obtained using an unpaired non-parametric two-tailed
t-test (software program Instat, version 3.05; Graph Pad,
San Diego, CA).
Cross-link analysis
Skin samples were dissected from the back of normal (n¼ 5) and
Sagg/þ (n¼ 4) mice. After hair was shaved, the samples were cut
into small pieces with a razor blade, pulverized in liquid nitrogen
using a Spex Freezer Mill (Spex Industries Inc., Edison, NJ), washed
with distilled water, and lyophilized. Approximately 2 mg of each
sample was then suspended in 0.15 M N-trismethyl-2-aminoethane
sulfonic acid, pH 7.4, reduced with standardized NaB3H4, hydro-
lyzed with 6 N HCl, and subjected to quantitative collagen cross-link
analysis as described (Yamamoto and Yamauchi, 1999). The
quantities of the cross-links were expressed as mol/mol of collagen
using a value of 300 residues of hydroxyproline per collagen
molecule (Yamauchi and Shiiba, 2002).
Skin biomechanics
Skin was dissected posteriorly from normal (n¼ 5) and Sagg/þ
(n¼ 4) mice. A razorblade stamp was used to create two (superior
and inferior) dogbone-shaped skin specimens from each mouse. The
resulting specimens were oriented normal to the saggital plane and
the right side of each was marked to ensure consistency of direction.
Cross-sectional area was calculated based on measurements of
specimen geometry (thickness and width) using established proto-
cols (Soslowsky et al., 1994, 2000). Each specimen was marked with
lines demarcating the gage length for use in optical strain
measurements, as described previously (Derwin et al., 1994). Each
sample was clamped in custom test fixtures to facilitate mechanical
testing in an Instron 5,543 materials testing system (Instron Corp.,
Canton, MA). All specimens were subjected to the following testing
protocol, while submerged in 371C phosphate-buffered saline:
preload to 0.03 N, hold for 120 seconds, and constant ramp to
failure at a rate of 1.67%/second. Stress was calculated from the load
response divided by the measured cross-sectional area. Modulus was
calculated as the slope of the stress–strain curve within the elastic
region of the ramp to failure. The pairs of resulting properties for
each mouse were averaged to obtain a single value for each
property. Differences in means between normal and Sagg/þ mice
were compared using unpaired t-tests with significance set at
Pp0.05.
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